| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| N A Kressin, A M Nielsen, R Laravuso, G E Bisgar. Domperidone-induced potentiation of ventilatory responses in awake goats. Respiration physiology. vol 65. issue 2. 1986-11-14. PMID:3764121. |
domperidone allows study of carotid chemoreceptor dopaminergic activity in awake animals because of its high affinity for carotid body d2 dopamine receptors and its lack of cns effects. |
1986-11-14 |
2023-08-11 |
Not clear |
| K Yamada, M Tanaka, K Shibata, T Furukaw. Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats. Psychopharmacology. vol 90. issue 1. 1986-11-12. PMID:2945222. |
the results indicate that low doses of apomorphine, piribedil, 3-ppp, tl-99 or bromocriptine elicit yawning by stimulating dopamine d-2 receptors and striatal and septal dopaminergic systems may be related to the occurrence of yawning behavior. |
1986-11-12 |
2023-08-11 |
rat |
| E Miliaressis, J Malette, D Coulomb. The effects of pimozide on the reinforcing efficacy of central grey stimulation in the rat. Behavioural brain research. vol 21. issue 2. 1986-11-12. PMID:3755951. |
the fact that pimozide reduced the value of reward in an area containing only marginal amounts of dopaminergic cells adds support to the hypothesis that dopamine modulates reward indirectly. |
1986-11-12 |
2023-08-11 |
human |
| P Voorn, B Jorritsma-Byham, C Van Dijk, R M Buij. The dopaminergic innervation of the ventral striatum in the rat: a light- and electron-microscopical study with antibodies against dopamine. The Journal of comparative neurology. vol 251. issue 1. 1986-11-12. PMID:3760260. |
the dopaminergic innervation of the ventral striatum in the rat: a light- and electron-microscopical study with antibodies against dopamine. |
1986-11-12 |
2023-08-11 |
rat |
| H M Barros, S Braz, J R Leit. Effect of carbamazepine on dopamine release and reuptake in rat striatal slices. Epilepsia. vol 27. issue 5. 1986-11-07. PMID:3757939. |
to verify if carbamazepine acts presynaptically on dopaminergic neurons, reuptake and release of [3h]dopamine were measured in rat striatal slices in vitro. |
1986-11-07 |
2023-08-11 |
rat |
| W G Erwin, T F Turc. Current concepts in clinical therapeutics: Parkinson's disease. Clinical pharmacy. vol 5. issue 9. 1986-11-03. PMID:3530616. |
the clinical features of parkinsonism result from a depletion in dopaminergic transmission in the corpus striatum; the dopamine deficiency is caused by a loss of melanin-containing nerve cells within the substantia nigra and locus ceruleus. |
1986-11-03 |
2023-08-11 |
Not clear |
| K Muta, T Maki, K Kato, H Ibayash. [Aging in the dopaminergic regulation of the pituitary hormone secretion in men (I): Changes in the pituitary response to dopamine]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics. vol 23. issue 3. 1986-11-03. PMID:3761704. |
[aging in the dopaminergic regulation of the pituitary hormone secretion in men (i): changes in the pituitary response to dopamine]. |
1986-11-03 |
2023-08-11 |
Not clear |
| J Arita, F Kimur. Characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia. Endocrinology. vol 119. issue 4. 1986-10-30. PMID:3019639. |
in order to investigate the mechanism of prl action on dopamine synthesis in tuberoinfundibular dopaminergic (tida) neurons, in vitro dopamine synthesis in the median eminence of hypothalamic slices was compared between hyperprolactinemic and hypoprolactinemic rats, hyper- and hypoprolactinemia were induced in ovariectomized rats by repetitive injections of the dopamine antagonist haloperidol (halo) and the dopamine agonist bromocriptine (bromo), respectively. |
1986-10-30 |
2023-08-11 |
rat |
| L T Jarjour, D J Handelsman, W J Raum, R S Swerdlof. Mechanism of action of dopamine on the in vitro release of gonadotropin-releasing hormone. Endocrinology. vol 119. issue 4. 1986-10-30. PMID:3019641. |
controversy exists on whether dopamine (da) stimulates or inhibits gnrh secretion and whether its effects are mediated via alpha-adrenergic receptors or dopaminergic receptors. |
1986-10-30 |
2023-08-11 |
rat |
| G Zsilla, P Földi, G Held, A M Székely, J Knol. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline. Polish journal of pharmacology and pharmacy. vol 38. issue 1. 1986-10-30. PMID:3020531. |
beside the augmentation of the dopamine turnover rate, the dopaminergic tone was also elevated by the reduction of the dopamine uptake in the striatum. |
1986-10-30 |
2023-08-11 |
rat |
| P Soares-da-Silv. Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. Naunyn-Schmiedeberg's archives of pharmacology. vol 333. issue 3. 1986-10-30. PMID:3762736. |
these results suggest the existence of a non-precursor dopamine pool in noradrenergic neurones supplying the proximal branches of the dog mesenteric artery, and also provide evidence in favour of the absence of independent dopaminergic neurones in this vascular area. |
1986-10-30 |
2023-08-11 |
dog |
| G F Di Renzo, S Amoroso, M Taglialatela, L Annunziat. Endogenous dopamine release from tuberoinfundibular neurons: does calmodulin play any role? Naunyn-Schmiedeberg's archives of pharmacology. vol 333. issue 3. 1986-10-30. PMID:3762737. |
the possible involvement of calmodulin in the process of endogenous dopamine (da) release from arcuate-periventricular nuclei-median eminence fragments, containing tuberoinfundibular dopaminergic (tida) neurons, has been investigated in an in vitro incubation system. |
1986-10-30 |
2023-08-11 |
Not clear |
| P K Sonsalla, J W Gibb, G R Hanso. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. The Journal of pharmacology and experimental therapeutics. vol 238. issue 3. 1986-10-23. PMID:2943891. |
previous studies have demonstrated that the effects of methamphetamine (meth) on dopaminergic and serotonergic systems are likely related to meth-induced increases in dopamine release. |
1986-10-23 |
2023-08-11 |
Not clear |
| A M Johansson, A Karlén, C J Grol, S Sundell, L Kenne, U Hacksel. Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences. Molecular pharmacology. vol 30. issue 3. 1986-10-21. PMID:2943981. |
dopaminergic 2-aminotetralins: affinities for dopamine d2-receptors, molecular structures, and conformational preferences. |
1986-10-21 |
2023-08-11 |
Not clear |
| E Mogilnicka, K Wedzony, V Klimek, A Czyra. Desipramine induces yawning behaviour in rats. Neuropharmacology. vol 25. issue 7. 1986-10-21. PMID:3748326. |
these findings indicate that desipramine induces yawning by a dopaminergic mechanism, and that endogenous dopamine (da) is necessary for its occurrence. |
1986-10-21 |
2023-08-11 |
rat |
| S Li, G Pelletie. The role of dopamine in the control of neuropeptide Y neurons in the rat arcuate nucleus. Neuroscience letters. vol 69. issue 1. 1986-10-20. PMID:3528937. |
in order to determine the role of dopamine (da) on neuropeptide y (npy) neurons in the arcuate nucleus of the rat hypothalamus, we evaluated the effects of alpha-methylparatyrosine (alpha-mpt), an inhibitor of catecholamines biosynthesis, and haloperidol, a dopaminergic antagonist, on npy immunoreactive neurons. |
1986-10-20 |
2023-08-11 |
rat |
| N E Goeders, J E Smit. Reinforcing properties of cocaine in the medical prefrontal cortex: primary action on presynaptic dopaminergic terminals. Pharmacology, biochemistry, and behavior. vol 25. issue 1. 1986-10-16. PMID:3018792. |
dopamine self-administration was attenuated by including equimolar concentrations of the d2 dopaminergic antagonist sulpiride in the injectate. |
1986-10-16 |
2023-08-11 |
rat |
| G J Treisman, N Muirhead, M E Gneg. Increased sensitivity of adenylate cyclase activity in the striatum of the rat to calmodulin and GppNHp after chronic treatment with haloperidol. Neuropharmacology. vol 25. issue 6. 1986-10-16. PMID:3092124. |
chronic treatment of rats with haloperidol causes behavioral supersensitivity to dopaminergic agonists and an increase in the sensitivity of adenylate cyclase activity in the striatum to stimulation by dopamine. |
1986-10-16 |
2023-08-11 |
rat |
| G Gianutsos, S Chut. Pharmacological changes induced by repeated exposure to phenylethylamine. Pharmacology, biochemistry, and behavior. vol 25. issue 1. 1986-10-16. PMID:3749219. |
striatal dopamine receptors, labelled by spiroperidol, were increased after the long-term pea, suggesting that the sensitization may be due to increased dopaminergic receptor activity. |
1986-10-16 |
2023-08-11 |
mouse |
| D K Armstrong, J F Dasta, T E Reilley, R D Tallma. Effect of haloperidol on dopamine-induced increase in renal blood flow. Drug intelligence & clinical pharmacy. vol 20. issue 7-8. 1986-10-10. PMID:3743409. |
this response is mediated in part by stimulation of dopaminergic receptors in the kidney, which could be attenuated by the dopamine blocker haloperidol. |
1986-10-10 |
2023-08-11 |
Not clear |